PROGNOSTIC VALUE OF CENTRAL VENOUS -ARTERIAL CO₂ DIFFERENCE TO ARTERIAL - CENTRAL VENOUS O₂ DIFFERENCE RATIO IN PEDIATRIC SEPTIC SHOCK

Hùng Đậu Việt, Sơn Nguyễn Hoàng

Main Article Content

Abstract

Objective: Septic shock is a condition characterized by an imbalance between oxygen supply and consumption, leading to tissue hypoxia, multi-organ failure, and high mortality rates. Early identification of tissue hypoxia is a critical factor in treating shock. The study aims to assess the predictive value of the central venous -arterial CO₂ difference (Cv-aCO₂) to arterial - central venous O₂ difference (Da-vO₂) ratio in managing pediatric patients with septic shock. Methods: This was a prospective descriptive study. All children diagnosed with septic shock were included. The Cv-aCO₂ and Da-vO₂ indices were collected and calculated from central venous and arterial blood gases using the GEM 3500 analyzer at specific time points: T0 (at the start of shock treatment), T6 (6 hours post-treatment), T12 (12 hours post-treatment), and T24 (24 hours post-treatment). Treatment outcomes were assessed based on duration of mechanical ventilation (days), length of stay in the intensive care unit (ICU) (days), and survival or mortality. Results: Among the 81 patients included in the study, 64 patients survived (79%), with a median mechanical ventilation duration of 9.1 days (range: 0–28) and a median ICU stay of 12.3 days (range: 1–28). The Cv-aCO₂/Da-vO₂ ratio cutoff value of 1 at the start of treatment (T0) allowed differentiation between the survival and mortality groups, with an ROC of 0.604 (95% CI: 0.45–0.76), sensitivity of 76.6%, and specificity of 88%. The Cv-aCO₂/Da-vO₂ ratio was significantly associated with the prognosis for mechanical ventilation duration and ICU length of stay. Conclusion: The Cv-aCO₂/Da-vO₂ ratio is a promising index for evaluating mechanical ventilation duration, ICU length of stay, and mortality prognosis in pediatric patients with septic shock

Article Details

References

1. Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020 Feb;46(Suppl 1):10-67. doi: 10.1007/s00134-019-05878-6.
2. Ospina-Tascón GA, Umaña M, Bermúdez W, et al. Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O2 content difference ratio as markers of resuscitation in patients with septic shock. Intensive Care Med. 2015; 41(5): 796-805. doi:10.1007/s00134-015-3720-6
3. Ospina-Tascón GA, Madriñán HJ. Combination of O2 and CO2-derived variables to detect tissue hypoxia in the critically ill patient. J Thorac Dis. 2019;11 (Suppl 11):S1544-S1550. doi:10.21037/ jtd.2019.03.52.
4. Zang H, Shen X, Wang S, He Z, Cheng H. Evaluation and prognostic value of Cv-aCO2/Da-vO2 in patients with septic shock receiving fluid resuscitation Cv-aCO2/Ca-vO2. Exp Ther Med. 2019;18(5): 3631-3635. doi:10.3892/etm. 2019.7956
5. He H, Liu D, Long Y, et al. High central venous-to-arterial CO2 difference/arterial-central venous O2 difference ratio is associated with poor lactate clearance in septic patients after resuscitation. J Crit Care. 2016;31(1):76-81. doi:10.1016/j.jcrc. 2015.10.017.
6. He H, Long Y, Liu D, et al. The Prognostic Value of Central Venous-to-Arterial CO2 Difference/Arterial-Central Venous O2 Difference Ratio in Septic Shock Patients with Central Venous O2 Saturation ≥80%: SHOCK. 2017;48(5):551-557. doi:10.1097/SHK.0000000000000893.
7. Mesquida J, Saludes P, Gruartmoner G, et al. Central venous-to-arterial carbon dioxide difference combined with arterial-to-venous oxygen content difference is associated with lactate evolution in the hemodynamic resuscitation process in early septic shock. Crit Care Lond Engl. 2015;19:126. doi:10.1186/ s13054-015-0858-0
8. Wang X, Gao X, Cao W, et al. Prognostic value of arterial lactate combined with central venous-to-arterial carbon dioxide difference to arterial-to-central venous oxygen content difference ratio in septic shock patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jan;32(1):39-43. doi: 10.3760/cma.j.cn121430-20191226-00007.